secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuphoria Therapeutics Inc. (NEUP)
CIK:        0001191070
Form:       8-K
Filed at:   2025-01-14T23:59:59+00:00
Accession:  0001213900-25-003492
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Neuphoria Therapeutics regains Nasdaq minimum bid price compliance
------------------------------------------------------------------

- Received Nasdaq letter confirming compliance with Minimum Bid Price Rule 5450(a)(1) on Jan 10, 2025.
- Common stock (NEUP) closed at $1.00 or higher for 10 consecutive business days from Dec 24, 2024 to Jan 8, 2025.
- Deficiency letter previously disclosed in July 2024; compliance deadline was Jan 7, 2025.
- Matter is now closed; company avoids potential delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1191070/000121390025003492/0001213900-25-003492-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1191070/000121390025003492/ea0227706-8k_neupho.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-003492

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer